PubMed

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC.

Nutr Metab (Lond). 2009 Aug 10;6:31.PMID: 19664276 [PubMed - in process]Related articlesFree article

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators.

Lancet Neurol. 2008 Jun;7(6):483-93. Epub 2008 Apr 29. Erratum in: Lancet Neurol. 2008 Jul;7(7):575. PMID: 18450517 [PubMed - indexed for MEDLINE]Related articles

Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.

De Jesus Moreno Moreno M.

Clin Ther. 2003 Jan;25(1):178-93.PMID: 12637119 [PubMed - indexed for MEDLINE]Related articles

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators.

Lancet. 2008 Jul 19;372(9634):207-15.PMID: 18640457 [PubMed - indexed for MEDLINE]Related articles

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.

Aronson S, Van Baelen B, Kavanagh S, Schwalen S.

Drugs Aging. 2009;26(3):231-9. doi: 10.2165/00002512-200926030-00004.PMID: 19358618 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group.

Jann MW, Cyrus PA, Eisner LS, Margolin DI, Griffin T, Gulanski B.

Clin Ther. 1999 Jan;21(1):88-102.PMID: 10090427 [PubMed - indexed for MEDLINE]Related articles

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.PMID: 14974068 [PubMed - indexed for MEDLINE]Related articles

Galantamine for Alzheimer's disease and mild cognitive impairment.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747. Review.PMID: 16437436 [PubMed - indexed for MEDLINE]Related articles

Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

Kanowski S, Hoerr R.

Pharmacopsychiatry. 2003 Nov;36(6):297-303.PMID: 14663654 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.

Curr Alzheimer Res. 2005 Jul;2(3):343-53.PMID: 15974900 [PubMed - indexed for MEDLINE]Related articles

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.

JAMA. 2003 Jun 4;289(21):2819-26.PMID: 12783912 [PubMed - indexed for MEDLINE]Related articlesFree article

Galantamine for Alzheimer's disease.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001747. PMID: 15495017 [PubMed - indexed for MEDLINE]Related articles

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95.PMID: 11606667 [PubMed - indexed for MEDLINE]Related articlesFree article

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.PMID: 10669911 [PubMed - indexed for MEDLINE]Related articles

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease.

Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P.

Curr Alzheimer Res. 2009 Dec 31. [Epub ahead of print]PMID: 20043816 [PubMed - as supplied by publisher]Related articles

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. LEADe.

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, Demicco DA, Breazna A; On behalf of the LEADe Investigators.

Neurology. 2010 Mar 3. [Epub ahead of print]PMID: 20200346 [PubMed - as supplied by publisher]Related articles

A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population.

Suh GH, Yeon Jung H, Uk Lee C, Hoon Oh B, Nam Bae J, Jung HY, Ju YS, Kil Yeon B, Park J, Hong I, Choi S, Ho Lee J; Korean Galantamine Study Group.

Clin Ther. 2004 Oct;26(10):1608-18.PMID: 15598477 [PubMed - indexed for MEDLINE]Related articles

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.

Blesa R, Davidson M, Kurz A, Reichman W, van Baelen B, Schwalen S.

Dement Geriatr Cogn Disord. 2003;15(2):79-87.PMID: 12566596 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease.

Pasqualetti P, Bonomini C, Dal Forno G, Paulon L, Sinforiani E, Marra C, Zanetti O, Rossini PM.

Aging Clin Exp Res. 2009 Apr;21(2):102-10.PMID: 19448381 [PubMed - indexed for MEDLINE]Related articles

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.

Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS.

Lancet Neurol. 2008 Apr;7(4):310-8. Epub 2008 Feb 28.PMID: 18296124 [PubMed - indexed for MEDLINE]Related articles